<p>The Diabetes Multi-omic Investigation of Drug Response (DIAMOND) cohort is a population-based cohort of individuals with type-2 diabetes (T2D) who receive their care through a large health system serving southeast Michigan and metropolitan Detroit. The cohort represents the diversity of the population from which it was created. Because of their health plan membership, participants have a rich dataset of longitudinal clinical health information related to their care. The intent of the DIAMOND study is to use genomic profiling, drug exposure information, and electronic health record (EHR) derived outcome data to identify genetic predictors of treatment response. Genome-wide genotyping was performed using the AxiomTM Precision Medicine Research Array (ThermoFisher Scientific Inc.).</p>

Diabetes Multi-Omic Investigation of Drug Response (DIAMOND)

18 variables across Anthropometry, Demographics, Medications + 1 more

Diabetes Multi-Omic Investigation of Drug Response (DIAMOND)

Anthropometry (2)

Demographics (3)

Medications (2)

Race and Ethnicity (2)

Other (9)